The Termeer Foundation
Michael Bonney is a seasoned professional in the pharmaceutical industry with a notable career highlighted by executive leadership roles. At Kaleido Biosciences, Michael served as Executive Chair as well as Chair and CEO from June 2017 to October 2020. Prior to that, Michael held a significant role at Cubist Pharmaceuticals before retiring. Michael earned a Bachelor of Arts in Economics from Bates College, completing studies from 1976 to 1980.
This person is not in the org chart
The Termeer Foundation
Building on the bold legacy of Henri Termeer, who pioneered groundbreaking treatments for rare diseases, The Termeer Foundation is a nonprofit organization focused on connecting life science innovators and catalyzing the creation of new medicines.